Buy Torrent Pharmaceuticals; target of Rs 3135: ICICI Direct
ICICI Direct is bullish on Torrent Pharmaceuticals recommended buy rating on the stock with a target price of Rs 3135 in its research report dated October 27, 2020.29-10-2020
29-10-2020
Hold Torrent Pharmaceuticals; target of Rs 2871: Sharekhan
Sharekhan recommended Hold rating on Torrent Pharmaceuticals with a target price of Rs 2871 in its research report dated October 26, 2020.28-10-2020
Torrent Pharma: Cost controls not enough, recovery in key markets crucial
Chronic and sub-chronic therapies, accounting for 77 per cent of India sales, are outperforming the domestic market, say analysts27-10-2020
Earnings Call for Q2FY21 Torrent Pharmaceuticals
Conference Call with Torrent Pharmaceuticals Management and Analysts on Q2FY21 Performance and Outlook. Listen to the full earnings transcript.26-10-2020
Torrent Pharma Q2 profit up 27% at Rs 310 cr on robust sales, low expenses
The company had posted a net profit of Rs 244 crore for the corresponding period of the previous fiscal, Torrent Pharmaceuticals said in a filing to BSE26-10-2020
TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Investor Presentation
The presentation on unaudited Consolidated Financial Results for the quarter and half year ended 30th September, 2020 to be made to analysts is enclosed for your records.26-10-2020
TORRENT PHARMACEUTICALS LTD. - 500420 - Submission / Intimation Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements), 2015, (''Listing Regulations'')
We would like to inform that the Board has at its meeting held today approved, inter-alia, the Audited Standalone Financial Results along with audit report thereon and Unaudited Consolidated Financial Results along with limited review report of the Company for the quarter and half year ended 30th September, 2020. The said financial results are enclosed herewith. In terms of Regulation 47 of the Listing Regulations, the Company will publish an extract of Unaudited Consolidated Financial Results for the quarter and half year ended on 30th September, 2020. Both Standalone and Consolidated* Financial Results will be available at Company''s website www.torrentpharma.com A Press Release on Financial Results which is being submitted to the media is also enclosed herewith.26-10-2020
TORRENT PHARMACEUTICALS LTD. - 500420 - Shareholding for the Period Ended September 30, 2020
Torrent Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2020. For more details, kindly Click here19-10-2020
TORRENT PHARMACEUTICALS LTD. - 500420 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of Issue of Duplicate Share Certificate16-10-2020
TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
We hereby inform that the Company has scheduled a teleconference with Investors / Analyst on 26th October, 2020 at 05:30 P.M. to discuss the financial performance of the Company for the quarter and half year ended 30th September, 2020.15-10-2020